Patrick Lin - 01 Apr 2025 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Reporting relationship: Chief Business - Strategy Off
Issuer ticker: PCSA
Reported as of: 01 Apr 2025
Net transaction value: -$1,983
SEC form: 4
Accepted by SEC: 11 Apr 2025, 17:22:45 UTC
Prior SEC filing: 18 Feb 2025
Next SEC filing: 18 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact

Key filing fact

Patrick Lin filed Form 4 for Processa Pharmaceuticals, Inc. (PCSA) on 11 Apr 2025.

Key facts

This page summarizes Patrick Lin's Form 4 filing for Processa Pharmaceuticals, Inc. (PCSA).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 11 Apr 2025, 17:22.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

Shares, units, or other non-derivative securities reported in this filing.

PCSA transaction

Options Exercise

PCSA transaction

Tax liability

PCSA holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Distribution of vested restricted shares